# SBRT or TACE for Advanced HCC

> **NCT03338647** · PHASE3 · UNKNOWN · sponsor: **University of Aarhus** · enrollment: 180 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** DEB
- **RADIATION:** SBRT

## Key facts

- **NCT ID:** NCT03338647
- **Lead sponsor:** University of Aarhus
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-26
- **Primary completion:** 2023-12-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2021-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03338647

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03338647, "SBRT or TACE for Advanced HCC". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT03338647. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*